| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 37 | 2025 | 1581 | 4.900 |
Why?
|
| Smoking | 20 | 2023 | 1032 | 2.780 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 1642 | 2.150 |
Why?
|
| Genetic Predisposition to Disease | 31 | 2023 | 3090 | 1.920 |
Why?
|
| Scleroderma, Systemic | 12 | 2019 | 117 | 1.910 |
Why?
|
| Polymorphism, Single Nucleotide | 28 | 2023 | 2595 | 1.590 |
Why?
|
| Early Detection of Cancer | 4 | 2025 | 347 | 1.380 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2025 | 333 | 1.260 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 131 | 0.960 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2025 | 2041 | 0.690 |
Why?
|
| Genome, Human | 10 | 2020 | 1266 | 0.680 |
Why?
|
| Genetic Variation | 6 | 2020 | 1479 | 0.660 |
Why?
|
| Models, Biological | 3 | 2011 | 1442 | 0.650 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 670 | 0.650 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2011 | 76 | 0.620 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 9 | 0.590 |
Why?
|
| DNA Repair | 3 | 2012 | 582 | 0.570 |
Why?
|
| Breath Tests | 1 | 2017 | 179 | 0.570 |
Why?
|
| Models, Statistical | 7 | 2019 | 475 | 0.550 |
Why?
|
| Case-Control Studies | 19 | 2020 | 3259 | 0.540 |
Why?
|
| Quantitative Trait Loci | 6 | 2022 | 282 | 0.530 |
Why?
|
| Genomic Imprinting | 3 | 2007 | 123 | 0.530 |
Why?
|
| Mutation, Missense | 10 | 2024 | 845 | 0.520 |
Why?
|
| Neoplasms | 8 | 2020 | 2750 | 0.510 |
Why?
|
| Diet | 2 | 2013 | 1125 | 0.490 |
Why?
|
| Humans | 75 | 2025 | 122997 | 0.480 |
Why?
|
| Carcinogenesis | 1 | 2017 | 328 | 0.460 |
Why?
|
| Gene Frequency | 7 | 2022 | 714 | 0.460 |
Why?
|
| Genetic Linkage | 4 | 2007 | 454 | 0.460 |
Why?
|
| Models, Genetic | 4 | 2008 | 767 | 0.460 |
Why?
|
| Risk Factors | 23 | 2023 | 9974 | 0.450 |
Why?
|
| Alleles | 6 | 2020 | 1602 | 0.440 |
Why?
|
| Multivariate Analysis | 4 | 2022 | 1417 | 0.430 |
Why?
|
| Sex Factors | 4 | 2011 | 1254 | 0.430 |
Why?
|
| Introns | 1 | 2014 | 302 | 0.430 |
Why?
|
| Betaine | 1 | 2013 | 22 | 0.420 |
Why?
|
| Neoplasm Staging | 4 | 2025 | 1215 | 0.420 |
Why?
|
| Choline | 1 | 2013 | 55 | 0.420 |
Why?
|
| Selection, Genetic | 3 | 2024 | 155 | 0.410 |
Why?
|
| Middle Aged | 27 | 2020 | 25931 | 0.400 |
Why?
|
| Male | 40 | 2025 | 59901 | 0.390 |
Why?
|
| Models, Theoretical | 1 | 2014 | 357 | 0.390 |
Why?
|
| Computer Simulation | 6 | 2025 | 636 | 0.390 |
Why?
|
| Logistic Models | 8 | 2022 | 1796 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2023 | 1874 | 0.370 |
Why?
|
| Odds Ratio | 6 | 2022 | 1245 | 0.360 |
Why?
|
| Aged | 21 | 2020 | 19035 | 0.360 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 671 | 0.350 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 154 | 0.350 |
Why?
|
| Female | 36 | 2025 | 65309 | 0.340 |
Why?
|
| SEER Program | 2 | 2025 | 193 | 0.330 |
Why?
|
| Genetic Loci | 4 | 2016 | 338 | 0.320 |
Why?
|
| Biological Evolution | 4 | 2015 | 221 | 0.310 |
Why?
|
| Body Size | 1 | 2007 | 52 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 73 | 0.280 |
Why?
|
| Research Design | 1 | 2011 | 688 | 0.280 |
Why?
|
| Prostatic Neoplasms | 5 | 2017 | 1515 | 0.270 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 80 | 0.250 |
Why?
|
| Feeding Behavior | 1 | 2011 | 696 | 0.250 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 229 | 0.240 |
Why?
|
| Melanoma | 2 | 2023 | 836 | 0.240 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 804 | 0.230 |
Why?
|
| Oncogenes | 2 | 2022 | 169 | 0.230 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 1684 | 0.230 |
Why?
|
| Family | 1 | 2007 | 576 | 0.230 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 760 | 0.220 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2014 | 9 | 0.220 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 649 | 0.220 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 40 | 0.220 |
Why?
|
| Survival Analysis | 2 | 2025 | 1470 | 0.220 |
Why?
|
| Mutation | 4 | 2024 | 5773 | 0.210 |
Why?
|
| RNA Splicing | 3 | 2014 | 223 | 0.210 |
Why?
|
| Software | 1 | 2007 | 677 | 0.200 |
Why?
|
| Nucleotides | 1 | 2022 | 92 | 0.200 |
Why?
|
| Cohort Studies | 8 | 2023 | 4705 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2014 | 171 | 0.190 |
Why?
|
| Adult | 15 | 2023 | 28980 | 0.190 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 314 | 0.190 |
Why?
|
| Prognosis | 5 | 2023 | 4490 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 651 | 0.190 |
Why?
|
| Exons | 3 | 2014 | 795 | 0.190 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 175 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 180 | 0.190 |
Why?
|
| Conserved Sequence | 1 | 2022 | 293 | 0.190 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 6359 | 0.180 |
Why?
|
| Tumor Burden | 2 | 2012 | 230 | 0.180 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2848 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 162 | 0.180 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 92 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2023 | 327 | 0.170 |
Why?
|
| Genotype | 8 | 2018 | 2546 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2019 | 119 | 0.160 |
Why?
|
| Obesity | 2 | 2007 | 2227 | 0.150 |
Why?
|
| Telomerase | 1 | 2019 | 164 | 0.150 |
Why?
|
| Age Factors | 4 | 2011 | 2801 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2005 | 1542 | 0.150 |
Why?
|
| Octanes | 1 | 2017 | 1 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 77 | 0.150 |
Why?
|
| Furans | 1 | 2017 | 27 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 2048 | 0.150 |
Why?
|
| Computational Biology | 3 | 2015 | 799 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 159 | 0.150 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2020 | 1013 | 0.140 |
Why?
|
| Risk | 3 | 2020 | 750 | 0.140 |
Why?
|
| Genomics | 3 | 2014 | 1476 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2482 | 0.130 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2016 | 8 | 0.130 |
Why?
|
| CpG Islands | 4 | 2023 | 321 | 0.130 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2006 | 24 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 3657 | 0.130 |
Why?
|
| Age of Onset | 3 | 2012 | 581 | 0.130 |
Why?
|
| Blood | 1 | 2015 | 105 | 0.120 |
Why?
|
| Pedigree | 3 | 2020 | 1582 | 0.120 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 311 | 0.120 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 991 | 0.120 |
Why?
|
| beta Karyopherins | 1 | 2014 | 12 | 0.120 |
Why?
|
| Genes, p53 | 2 | 2005 | 212 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 247 | 0.120 |
Why?
|
| Likelihood Functions | 2 | 2005 | 112 | 0.110 |
Why?
|
| HLA Antigens | 2 | 2014 | 243 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 83 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 85 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 218 | 0.110 |
Why?
|
| Lung | 2 | 2023 | 1468 | 0.110 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2012 | 1 | 0.100 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1430 | 0.100 |
Why?
|
| Europe | 4 | 2019 | 371 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2003 | 150 | 0.100 |
Why?
|
| Food, Organic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 23 | 0.100 |
Why?
|
| Autoantibodies | 2 | 2011 | 422 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2011 | 607 | 0.100 |
Why?
|
| Selection Bias | 1 | 2011 | 21 | 0.090 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 42 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1524 | 0.090 |
Why?
|
| Registries | 3 | 2012 | 1382 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 39 | 0.090 |
Why?
|
| Vitamin A | 1 | 2011 | 60 | 0.090 |
Why?
|
| Carotenoids | 1 | 2011 | 75 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 554 | 0.090 |
Why?
|
| Phenotype | 5 | 2012 | 4221 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2010 | 82 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2011 | 370 | 0.090 |
Why?
|
| Fruit | 1 | 2011 | 221 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 101 | 0.080 |
Why?
|
| Forecasting | 1 | 2011 | 355 | 0.080 |
Why?
|
| Texas | 3 | 2013 | 3542 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 69 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 261 | 0.080 |
Why?
|
| Disease | 1 | 2010 | 130 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 793 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 487 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 1267 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1005 | 0.080 |
Why?
|
| Asthma | 2 | 2006 | 746 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 520 | 0.070 |
Why?
|
| Disease Progression | 1 | 2014 | 2027 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 280 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 26 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 426 | 0.070 |
Why?
|
| Mutagens | 1 | 2007 | 84 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1115 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2019 | 423 | 0.070 |
Why?
|
| Proteins | 1 | 2012 | 1038 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2023 | 991 | 0.070 |
Why?
|
| Dust | 1 | 2006 | 20 | 0.070 |
Why?
|
| Age Distribution | 1 | 2007 | 410 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2008 | 189 | 0.070 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 42 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 549 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2023 | 1335 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2007 | 771 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 62 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 156 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1400 | 0.060 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 16 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2007 | 385 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 32 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 293 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2105 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 37 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2002 | 43 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 85 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 92 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 3325 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 109 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 119 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 238 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2003 | 180 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2002 | 138 | 0.050 |
Why?
|
| Haplotypes | 2 | 2014 | 519 | 0.050 |
Why?
|
| Siblings | 1 | 2002 | 195 | 0.050 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 371 | 0.040 |
Why?
|
| Jews | 1 | 2020 | 31 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 614 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2014 | 212 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 2940 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 31 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 204 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 478 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 538 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 666 | 0.040 |
Why?
|
| Child | 3 | 2018 | 24144 | 0.040 |
Why?
|
| Mucins | 1 | 2019 | 74 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2018 | 66 | 0.040 |
Why?
|
| Algorithms | 3 | 2012 | 1596 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 48 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2009 | 6023 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 573 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 142 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 671 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 471 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 120 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 671 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 353 | 0.030 |
Why?
|
| Mass Screening | 2 | 2012 | 786 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 8840 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12087 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 13819 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2014 | 1021 | 0.030 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Microchip Analytical Procedures | 1 | 2014 | 6 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 15930 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 47 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 2837 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 278 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 118 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 19029 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 402 | 0.030 |
Why?
|
| United States | 3 | 2012 | 10595 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 244 | 0.030 |
Why?
|
| Calibration | 1 | 2012 | 89 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2012 | 75 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 249 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2011 | 20 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 20 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 33 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 294 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 469 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2533 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 228 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 147 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 1845 | 0.020 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 7 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 59 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 165 | 0.020 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 34 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1993 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 1498 | 0.020 |
Why?
|
| Bleomycin | 1 | 2007 | 150 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 259 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17469 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 426 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8070 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 120 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 50 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 66 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3047 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2005 | 93 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 37 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 54 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 12286 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1695 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5031 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 33693 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 465 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 522 | 0.010 |
Why?
|